Screener
Collegium Pharmaceutical, Inc. COLL Segment — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gain on fair value remeasurement of contingent consideration | — | (358) | — | (1,144) |
| Total operating expenses | 106,594 | 73,279 | 192,944 | 148,916 |
| Income from operations | 3,698 | 35,105 | 34,594 | 56,792 |
| Interest expense | (19,519) | (20,463) | (35,381) | (41,253) |
| Interest income | 2,289 | 2,383 | 5,995 | 4,608 |
| (Loss) income before income taxes | (13,532) | 17,025 | 5,208 | 20,147 |
| Provision for income taxes | 1,519 | 5,042 | 5,763 | 5,747 |
| Net (loss) income | $(15,051) | $11,983 | $(555) | $14,400 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s segment — interest expense?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — interest expense of $19.52M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — interest expense changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — interest expense decreased by 4.6% year-over-year, from $20.46M to $19.52M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — interest expense?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — interest expense has grown at a 9.2% compound annual growth rate (CAGR), from $63.21M to $82.31M.
- What does segment — interest expense mean?
- Reflects the cost of servicing the company's debt obligations, including interest payments on loans and credit facilities. This metric is a key indicator of the company's financial leverage and the burden of its capital structure on net income.
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude